![Dougal Sofien Bendjaballah](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dougal Sofien Bendjaballah
Algemeen Directeur bij Medovent GmbH
Oorsprong van het eerstegraads netwerk van Dougal Sofien Bendjaballah
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Medovent GmbH
![]() Medovent GmbH Medical SpecialtiesHealth Technology Medovent GmbH engages in the development and manufacture of medical devices made of the biopolymer chitosan. Its main products are a nerve guide used for peripheral nerve injuries and a direct suture for short nerve defects. The company was founded by Rivelino Montenegro and Thomas Freier in 2006 and is headquartered in Mainz, Germany.
6
| Subsidiary | Medical Specialties | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Dougal Sofien Bendjaballah via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Eberhard Karls Universität Tübingen | College/University | Corporate Officer/Principal | |
The HENLEY College | College/University | Masters Business Admin | |
The Johannes Gutenberg University of Mainz | College/University | Doctorate Degree | |
Max Planck Institute of Colloids & Interfaces | College/University | Doctorate Degree | |
5K Investment GmbH
![]() 5K Investment GmbH Financial ConglomeratesFinance 5K Investment GmbH engages in the provision of investment and financing support services. The firm’s investment activities focus on a range of businesses, including those operating in the medical technology, architecture, manufacturing and digital platform development. Its focus areas encompass investment management, business acquisition and financing operations. The company was founded by Hellmut Kirchner in June 2002 and is headquartered in Tutzing, Germany. | Financial Conglomerates | Chief Executive Officer | |
BiognoSYS AG
![]() BiognoSYS AG Packaged SoftwareTechnology Services BiognoSYS AG operates as a biotechnology company. Its products include iRT Kit, HRM Kit, Sample Prep Kit, PlasmaDive, Spectronaut and SpectroDive. The company was founded by Philipp M. Antoni, Johan Malmstroem and Oliver Rinner on September 3, 2008 and is headquartered in Schlieren, Switzerland. | Packaged Software | Director/Board Member | |
Mountain Partners AG
![]() Mountain Partners AG Investment ManagersFinance Mountain Partners AG is a private equity and venture capital firm headquartered in Germany. The firm founded in 2005 by Dr. Cornelius Boersch and Daniel S. Wenzel. | Investment Managers | Chairman | |
Evotec (München) GmbH
![]() Evotec (München) GmbH Chemicals: Major DiversifiedProcess Industries Part of Evotec SE, Evotec (München) GmbH is a German company that provides manufacturing and research support services for pharmaceutical and biotechnology companies. The company is based in Neuried, Germany. The CEOs are Dirk Ullmann, Loëtitia Edith Rouxel. The company was founded in 2005 by Axel Ullrich, Hellmut Kirchner, Henrik Daub. Evotec (München was acquired by Evotec SE on April 19, 2011 for $20.40 million. | Chemicals: Major Diversified | Founder | |
QIAGEN GmbH
![]() QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany. | Miscellaneous Commercial Services | Founder | |
HS LifeSciences GmbH | Investment Managers | Founder | |
ETHRIS GmbH
![]() ETHRIS GmbH Miscellaneous Commercial ServicesCommercial Services ETHRIS GmbH is a German company that specializes in developing innovative therapies and vaccines using its proprietary messenger RNA technology platform. The company is based in Planegg, Germany. The company is a leader in delivering stabilized mRNA directly to the respiratory system via optimized formulation and nebulization technologies. ETHRIS is rapidly advancing its pipeline of immuno-modulation, protein replacement therapies, and differentiated vaccines, with the ultimate goal of improving patients' lives. The company was founded by Carsten Rudolph and Christian Plank, and Carsten Rudolph has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Qiagen SRL
![]() Qiagen SRL Medical SpecialtiesHealth Technology Qiagen SRL is engaged in providing assay technologies. The company is headquartered in Milan, Italy. | Medical Specialties | Founder | |
Technische Universität Darmstadt | College/University | Doctorate Degree | |
DIB Doblinger Industriebeteiligung GmbH & Co. Holding KG
![]() DIB Doblinger Industriebeteiligung GmbH & Co. Holding KG Financial ConglomeratesFinance DIB Doblinger Industriebeteiligung GmbH & Co. Holding KG is a private equity firm. The company is based in Munich, Germany. | Financial Conglomerates | Corporate Officer/Principal | |
QIAGEN N.V. | Medical Specialties | Founder | |
EVOTEC SE | Pharmaceuticals: Major | Founder | |
U3 Pharma AG
![]() U3 Pharma AG Miscellaneous Commercial ServicesCommercial Services U3 Pharma AG researches and develops novel targeted therapeutics aimed at treating human disease. It develops products for hyperproliferative diseases such as cancer and commercializes human monoclonal antibody therapies directed against validated proprietary drug targets selected from its portfolio. In addition, it has created a second generation functional genomics platform, TASC, which mimics the progression of a tumor cell as it progresses towards its fully malignant cancerous state. Founded in 2001, the company is headquartered in Martinsried, Germany. | Miscellaneous Commercial Services | President | |
QureInvest AG
![]() QureInvest AG Investment ManagersFinance QureInvest AG targets seed and early stage companies located in Germany and Switzerland. It seeks investments in biotechnology and life sciences firms. | Investment Managers | Founder | |
Ruprecht-Karls-Universität Heidelberg | College/University | Corporate Officer/Principal |
Statistieken
Internationaal
Duitsland | 15 |
Zwitserland | 5 |
Verenigd Koninkrijk | 2 |
Italië | 2 |
Nederland | 2 |
Sectoraal
Finance | 7 |
Consumer Services | 7 |
Commercial Services | 5 |
Health Technology | 4 |
Technology Services | 2 |
Operationeel
Founder | 9 |
Director/Board Member | 8 |
Corporate Officer/Principal | 4 |
Doctorate Degree | 3 |
President | 2 |
Sterkste connecties
- Beurs
- Insiders
- Dougal Sofien Bendjaballah
- Bedrijfsconnecties